Kamran Alimoghadam

515 total citations
23 papers, 430 citations indexed

About

Kamran Alimoghadam is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Kamran Alimoghadam has authored 23 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Kamran Alimoghadam's work include Chronic Myeloid Leukemia Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Kamran Alimoghadam is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Kamran Alimoghadam collaborates with scholars based in Iran and Australia. Kamran Alimoghadam's co-authors include Ardeshir Ghavamzadeh, Farideh Khosravi, Aliakbar Amirzargar, Amir‐Hassan Zarnani, Somaieh Kazemnejad, Manijeh Khanmohammadi, Mohammad Mehdi Akhondi, Bita Ansaripour, Behrouz Nikbin and Morteza Bagheri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Molecular and Cellular Biochemistry.

In The Last Decade

Kamran Alimoghadam

23 papers receiving 424 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kamran Alimoghadam 112 92 90 82 78 23 430
Helen Koutala 162 1.4× 67 0.7× 118 1.3× 78 1.0× 38 0.5× 12 452
Angelo Tocci 75 0.7× 178 1.9× 144 1.6× 117 1.4× 118 1.5× 31 541
Satoshi Saida 92 0.8× 111 1.2× 48 0.5× 102 1.2× 74 0.9× 55 456
Maïlys Cren 146 1.3× 144 1.6× 68 0.8× 66 0.8× 54 0.7× 13 414
Irene Mavroudi 171 1.5× 133 1.4× 146 1.6× 154 1.9× 43 0.6× 37 456
Aki Sato 69 0.6× 97 1.1× 70 0.8× 188 2.3× 60 0.8× 46 466
Noriyuki Seta 181 1.6× 121 1.3× 60 0.7× 66 0.8× 53 0.7× 22 473
Keon-Il Im 156 1.4× 114 1.2× 226 2.5× 76 0.9× 77 1.0× 29 482
Tatjana Terzić 61 0.5× 156 1.7× 50 0.6× 54 0.7× 143 1.8× 50 561
Emily Mavin 166 1.5× 216 2.3× 117 1.3× 115 1.4× 52 0.7× 7 489

Countries citing papers authored by Kamran Alimoghadam

Since Specialization
Citations

This map shows the geographic impact of Kamran Alimoghadam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamran Alimoghadam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamran Alimoghadam more than expected).

Fields of papers citing papers by Kamran Alimoghadam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamran Alimoghadam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamran Alimoghadam. The network helps show where Kamran Alimoghadam may publish in the future.

Co-authorship network of co-authors of Kamran Alimoghadam

This figure shows the co-authorship network connecting the top 25 collaborators of Kamran Alimoghadam. A scholar is included among the top collaborators of Kamran Alimoghadam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamran Alimoghadam. Kamran Alimoghadam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kerachian, Mohammad Amin, Seied Asadollah Mousavi, Kamran Alimoghadam, et al.. (2021). Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study. Annals of Hematology. 100(10). 2621–2631. 9 indexed citations
2.
Mohammadi, Saeed, Seyed H. Ghaffari, Mohsen Nikbakht, et al.. (2016). Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Life Sciences. 152. 190–198. 28 indexed citations
3.
Nasli‐Esfahani, Ensieh, et al.. (2015). Administration of autologous hematopoietic stem cell trans-plantation for treatment of type 1 diabetes mellitus.. Majallah-i bihdāsht-i Īrān. 44(2). 55–68. 2 indexed citations
4.
Alimoghadam, Kamran, et al.. (2014). EFFICACY AND SIDE EFFECTS OF MAINTENANCE THERAPY WITH THALIDOMIDE FOLLOWING STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Bābul. 16(7). 23–28. 1 indexed citations
5.
Sayehmiri, Kourosh, et al.. (2014). Effects of aGVHD and cGVHD according to relapse status on survival rate in patients with acute lymphocytic leukemia. Hematology. 19(8). 441–447. 4 indexed citations
6.
Jahangard‐Rafsanjani, Zahra, Kheirollah Gholami, Molouk Hadjibabaie, et al.. (2013). The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial. Bone Marrow Transplantation. 48(6). 832–836. 41 indexed citations
7.
Khanmohammadi, Manijeh, Sayeh Khanjani, Amir‐Hassan Zarnani, et al.. (2012). Proliferation and chondrogenic differentiation potential of menstrual blood- and bone marrow-derived stem cells in two-dimensional culture. International Journal of Hematology. 95(5). 484–493. 43 indexed citations
8.
Kazemnejad, Somaieh, Mohammad Mehdi Akhondi, Masoud Soleimani, et al.. (2012). Characterization and Chondrogenic Differentiation of Menstrual Blood-Derived Stem Cells on a Nanofibrous Scaffold. The International Journal of Artificial Organs. 35(1). 55–66. 46 indexed citations
9.
10.
Behmanesh, Mehrdad, et al.. (2009). DEVELOPMENT OF A QUANTITATIVE REAL-TIME PCR FOR MICROMETASTASIS DETECTION USING CEA IN PERIPHERAL BLOOD AND BONE MARROW SPECIMENS OF GASTRIC CANCER PATIENTS. Tehran University Medical Journal TUMS Publications. 67(8). 542–548. 1 indexed citations
11.
Gholamrezanezhad, Ali, et al.. (2009). Cytotoxicity of 111In-oxine on mesenchymal stem cells: a time-dependent adverse effect. Nuclear Medicine Communications. 30(3). 210–216. 45 indexed citations
12.
Alimoghadam, Kamran, et al.. (2008). The Efficient Generation of Immunocompetent Dendritic Cells from Leukemic Blasts in Acute Myeloid Leukemia: A Local Experience. Pathology & Oncology Research. 15(2). 257–267. 2 indexed citations
13.
Gholamrezanezhad, Ali, Mohammad Bagheri, Sahar Mirpour, et al.. (2007). The first experience of stem cell labeling in Iran using 111In- Oxine [Persian]. 15(2). 25–27. 1 indexed citations
14.
Amirzargar, Aliakbar, et al.. (2007). Association of HLA class II allele and haplotype frequencies with chronic myelogenous leukemia and age-at-onset of the disease. Pathology & Oncology Research. 13(1). 47–51. 14 indexed citations
15.
Haghpanah, Vahid, et al.. (2007). Vitamin D receptor gene polymorphisms in patients with thyroid cancer. 9 indexed citations
16.
Khosravi, Farideh, Aliakbar Amirzargar, Mohammad Hossein Nicknam, et al.. (2007). HLA class II allele and haplotype frequencies in Iranian patients with leukemia.. PubMed. 6(3). 137–42. 16 indexed citations
17.
Amirzargar, Aliakbar, Morteza Bagheri, Ardeshir Ghavamzadeh, et al.. (2005). Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. International Journal of Immunogenetics. 32(3). 167–171. 77 indexed citations
18.
19.
Ghavamzadeh, Ardeshir, et al.. (2002). "Thalassemia: Incidence and predictive factors for chronic GVHD after HLA-identical sibling marrow transplantation ". SHILAP Revista de lepidopterología. 2 indexed citations
20.
Alimoghadam, Kamran, et al.. (1999). Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. Bone Marrow Transplantation. 23(3). 299–301. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Koutala Breakdown of academic impact, for papers by Angelo Tocci Breakdown of academic impact, for papers by Satoshi Saida Breakdown of academic impact, for papers by Maïlys Cren Breakdown of academic impact, for papers by Irene Mavroudi Breakdown of academic impact, for papers by Aki Sato Breakdown of academic impact, for papers by Noriyuki Seta Breakdown of academic impact, for papers by Keon-Il Im Breakdown of academic impact, for papers by Tatjana Terzić Breakdown of academic impact, for papers by Emily Mavin
Rankless by CCL
2026